Related references
Note: Only part of the references are listed.Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
Moritz Gerstung et al.
NATURE COMMUNICATIONS (2015)
QuasR: quantification and annotation of short reads in R
Dimos Gaidatzis et al.
BIOINFORMATICS (2015)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner
Huafeng Xie et al.
CELL STEM CELL (2014)
Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F
Pontus Lundberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model
Lucia Kubovcakova et al.
BLOOD (2013)
The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells
Michael R. Copley et al.
NATURE CELL BIOLOGY (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes
Hideyuki Oguro et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Tobias Neff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
被撤回的出版物: Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease (Retracted article. See vol. 8, Art no 14005, 2017)
A. Herrera-Merchan et al.
NATURE COMMUNICATIONS (2012)
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
Damian B. Yap et al.
BLOOD (2011)
EZH2 mutational status predicts poor survival in myelofibrosis
Paola Guglielmelli et al.
BLOOD (2011)
Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells
Makiko Mochizuki-Kashio et al.
BLOOD (2011)
New mutations and pathogenesis of myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2011)
Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Elena Piskounova et al.
CELL (2011)
Mouse models of myeloproliferative neoplasms: JAK of all grades
Juan Li et al.
DISEASE MODELS & MECHANISMS (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells
Ian J. Majewski et al.
BLOOD (2010)
A flexible R package for nonnegative matrix factorization
Renaud Gaujoux et al.
BMC BIOINFORMATICS (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
The 2008 World Health Organization Classification System for Myeloproliferative Neoplasms Order Out of Chaos
Ayalew Tefferi et al.
CANCER (2009)
Lin28 promotes transformation and is associated with advanced human malignancies
Srinivas R. Viswanathan et al.
NATURE GENETICS (2009)
Polycomb Limits the Neurogenic Competence of Neural Precursor Cells to Promote Astrogenic Fate Transition
Yusuke Hirabayashi et al.
NEURON (2009)
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Ralph Tiedt et al.
BLOOD (2008)
Selective blockade of MicroRNA processing by Lin28
Srinivas R. Viswanathan et al.
SCIENCE (2008)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion
LM Kamminga et al.
BLOOD (2006)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
In vivo fate-tracing studies using the Scl stem cell enhancer:: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis
JR Göthert et al.
BLOOD (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia
J Andrieux et al.
GENES CHROMOSOMES & CANCER (2004)
Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo
BC Schaefer et al.
CELLULAR IMMUNOLOGY (2001)
Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia
G Barosi et al.
BLOOD (2001)
The Polycomb-group gene Ezh2 is required for early mouse development
D O'Carroll et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
